NCT00584987View on ClinicalTrials.gov

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Allergic Rhinitis
Interventions
DRUG

Fluticasone furoate

2 puffs of each nasal spray in each nostril in the pm

DRUG

Placebo Fluticasone furoate

2 puffs of each nasal spray in each nostril in the pm

DRUG

Oxymetazoline

2 puffs of each nasal spray in each nostril in the pm

DRUG

Placebo Oxymetazoline

2 puffs of each nasal spray in each nostril in the pm

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Chicago

OTHER

NCT00584987 - Intranasal Steroids and Oxymetazoline in Allergic Rhinitis | Biotech Hunter | Biotech Hunter